Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting

Emma S. Wharfe, Catherine L. Winder, Roger M. Jarvis, Royston Goodacre

    Research output: Contribution to journalArticlepeer-review


    The effects of the chiral pharmaceuticals atenolol and propranolol on Pseudomonas putida, Pseudomonas aeruginosa, Micrococcus luteus, and Blastomonas natatoria were investigated. The growth dynamics of exposed cultures were monitored using a Bioscreen instrument. In addition, Fourier-transform infrared (FT-IR) spectroscopy with appropriate chemometrlcs and high-performance liquid chromatography (HPLC) were employed in order to investigate the phenotypic changes and possible degradation of the drugs in exposed cultures. For the majority of the bacteria studied there was not a statistically significant difference in the organism's phenotype when it was exposed to the different enantiomers or mixtures of enantiomers. In contrast, the pseudomonads appeared to respond differently to propranolol, and the two enantiomers had different effects on the cellular phenotype. This implies that there were different metabolic responses in the organisms when they were exposed to the different enantiomers. We suggest that our findings may indicate that there are widespread effects on aquatic communities in which active pharmaceutical ingredients are present. Copyright © 2010, American Society for Microbiology. All Rights Reserved.
    Original languageEnglish
    Pages (from-to)2075-2085
    Number of pages10
    JournalApplied and environmental microbiology
    Issue number7
    Publication statusPublished - Apr 2010


    Dive into the research topics of 'Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting'. Together they form a unique fingerprint.

    Cite this